These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 28245859)

  • 61. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
    Chung YL; Horng CF; Lee PI; Chen FL
    BMC Cancer; 2016 Mar; 16():179. PubMed ID: 26940959
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Definitive concurrent chemoradiotherapy in cervical cancer--a University of Malaya Medical Centre experience.
    Zamaniah WI; Mastura MY; Phua CE; Adlinda A; Marniza S; Rozita AM
    Asian Pac J Cancer Prev; 2014; 15(20):8987-92. PubMed ID: 25374241
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MRI- and PET-Guided Interstitial Brachytherapy for Postsurgical Vaginal Recurrences of Cervical Cancer: Results of Phase II Study.
    Chopra S; Engineer R; Shah S; Shukla R; Dora T; Gupta P; Paul SN; Popat P; Swamidas J; Mahantshetty U; Varghese L; Gupta S; Rangrajan V; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):310-319. PubMed ID: 31682968
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
    Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Radiochemotherapy of uterine cervix cancers. Recent data].
    Resbeut M; Haie-Meder C; Alzieu C; Gonzague-Casabianca L
    Cancer Radiother; 2000; 4(2):140-6. PubMed ID: 10812360
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
    Chen MF; Tseng CJ; Tseng CC; Yu CY; Wu CT; Chen WC
    Cancer J; 2008; 14(3):200-6. PubMed ID: 18536561
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Concomitant Chemoradiotherapy With Image-guided Pulsed Dose Rate Brachytherapy as a Definitive Treatment Modality for Early-stage Cervical Cancer.
    Refaat T; Castelain B; Small W; Elsaid A; Lotfy N; Lartigau E; Nickers P
    Am J Clin Oncol; 2015 Jun; 38(3):289-93. PubMed ID: 23799285
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association.
    Tattersall MH; Lorvidhaya V; Vootiprux V; Cheirsilpa A; Wong F; Azhar T; Lee HP; Kang SB; Manalo A; Yen MS
    J Clin Oncol; 1995 Feb; 13(2):444-51. PubMed ID: 7844607
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results.
    Liang JA; Chen SW; Chang WC; Hung YC; Yeh LS; Yang SN; Lin FJ
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):683-90. PubMed ID: 18676129
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
    Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term results of robotic radiosurgery for non brachytherapy patients with cervical cancer.
    Morgenthaler J; Köhler C; Budach V; Sehouli J; Stromberger C; Besserer A; Trommer M; Baues C; Marnitz S
    Strahlenther Onkol; 2021 Jun; 197(6):474-486. PubMed ID: 32970164
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.
    Keys HM; Bundy BN; Stehman FB; Muderspach LI; Chafe WE; Suggs CL; Walker JL; Gersell D
    N Engl J Med; 1999 Apr; 340(15):1154-61. PubMed ID: 10202166
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Outcomes and treatments of IB1 cervical cancers with high recurrence risk: A 13 years' experience.
    Espenel S; Garcia MA; Vallard A; Langrand-Escure J; Guy JB; Trone JC; Ben Mrad M; Chauleur C; de Laroche G; Moreno-Acosta P; Rancoule C; Magné N
    Cancer Radiother; 2018 Dec; 22(8):790-796. PubMed ID: 30348607
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix.
    Uno T; Mitsuhashi A; Isobe K; Yamamoto S; Kawakami H; Ueno N; Usui H; Tate S; Kawata T; Ito H
    Int J Gynecol Cancer; 2008; 18(1):80-4. PubMed ID: 17466053
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human cervical cancer clearance after 252Cf neutron brachytherapy versus conventional photon brachytherapy.
    Maruyama Y; Muir W
    Am J Clin Oncol; 1984 Aug; 7(4):347-52. PubMed ID: 6741864
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Extended-field intensity-modulated radiation therapy combined with concurrent chemotherapy for cervical cancer with para-aortic lymph nodes metastasis.
    Liu X; Wang W; Meng Q; Zhang F; Hu K
    Jpn J Clin Oncol; 2019 Mar; 49(3):263-269. PubMed ID: 30668725
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In-room computed tomography-based brachytherapy for uterine cervical cancer: results of a 5-year retrospective study.
    Ohno T; Noda SE; Okonogi N; Murata K; Shibuya K; Kiyohara H; Tamaki T; Ando K; Oike T; Ohkubo Y; Wakatsuki M; Saitoh JI; Nakano T
    J Radiat Res; 2017 Jul; 58(4):543-551. PubMed ID: 27986859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.